Bernd Kasper, Senior Attending Physician at University Hospital Mannheim, shared a post on LinkedIn:
“What a memorable day!
We are one step closer to the approval of the first and only therapy with marketing authorization in Europe for patients with desmoid tumors.
Proud to be part of this success story!”
More posts featuring desmoid tumors.